Your browser doesn't support javascript.
loading
EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.
Jia, Haibo; Dai, Jiannan; He, Luping; Xu, Yishuo; Shi, Yongfeng; Zhao, Lei; Sun, Zhiqi; Liu, Yin; Weng, Ziqian; Feng, Xue; Zhang, Dirui; Chen, Tao; Zhang, Xiling; Li, Lulu; Xu, Yousheng; Wu, Yanqing; Yang, Yining; Wang, Chunmei; Li, Lang; Li, Jianping; Hou, Jingbo; Liu, Bin; Mintz, Gary S; Yu, Bo.
Afiliación
  • Jia H; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Dai J; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • He L; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Xu Y; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Shi Y; Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.
  • Zhao L; Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.
  • Sun Z; Department of Cardiology, Daqing Oilfield General Hospital, Daqing, China.
  • Liu Y; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
  • Weng Z; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Feng X; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Zhang D; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Chen T; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Zhang X; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Li L; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Xu Y; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Wu Y; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yang Y; Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
  • Wang C; Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Li L; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Li J; Department of Cardiology, Peking University First Hospital, Beijing, China.
  • Hou J; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
  • Liu B; Department of Cardiology, The Second Hospital of Jilin University, Changchun, China. Electronic address: liubin3333@vip.sina.com.
  • Mintz GS; Cardiovascular Research Foundation, New York, New York, USA.
  • Yu B; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China. Electronic address: yubodr@163.com.
JACC Cardiovasc Interv ; 15(8): 846-856, 2022 04 25.
Article en En | MEDLINE | ID: mdl-35367176
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_ischemic_heart_disease Asunto principal: Intervención Coronaria Percutánea / Infarto del Miocardio con Elevación del ST / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: JACC Cardiovasc Interv Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_ischemic_heart_disease Asunto principal: Intervención Coronaria Percutánea / Infarto del Miocardio con Elevación del ST / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: JACC Cardiovasc Interv Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China